Treating delirium in a general hospital: A descriptive study of prescribing patterns and outcomes

International Psychogeriatrics

Volumn 22, Issue 2, 2010, Pages 328-331

  Briskman, Irena ^a   Dubinski, Ron ^a   Barak, Yoram ^b  

^a WOLFSON MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Delirium; Haloperidol; Mortality; Outcome; Risperidone; Treatment

Indexed keywords

HALOPERIDOL; NEUROLEPTIC AGENT; PERPHENAZINE; RISPERIDONE; SULPIRIDE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; COMORBIDITY; DELIRIUM; DEMENTIA; DESCRIPTIVE RESEARCH; FEMALE; GENERAL HOSPITAL; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; SEPSIS; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; CLINICAL PRACTICE; MIDDLE AGED; RETROSPECTIVE STUDY; STATISTICS;

ADULT; AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; DELIRIUM; DRUG PRESCRIPTIONS; FEMALE; HOSPITALS, GENERAL; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; RETROSPECTIVE STUDIES; RISPERIDONE; TREATMENT OUTCOME;

EID: 77950572689     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S1041610209990986     Document Type: Article

References (16)

1. Attard, A., Ranjith, G. and Taylor, D. (2008). Delirium and its treatment. CNS Drugs, 22, 631-644.
2. Boettger, S. and Breitbart, W. (2005). Atypical antipsychotics in the management of delirium: a review of the empirical literature. Palliative and Supportive Care, 3, 227-237.
3. Han, C. S. and Kim, Y. K. (2004). A double-blind trial of risperidone and haloperidol for the treatment of delirium. Psychosomatics, 45, 297-301.
4. Horikawa, N. et al. (2003). Treatment for delirium with risperidone: results of a prospective open trial with 10 patients. General Hospital Psychiatry, 25, 289-292.
5. Lacasse, H., Perreault, M. M. and Williamson, D. R. (2006). Systematic review of antipsychotics for the treatment of hospital-associated delirium in medically or surgically ill patients. Annals of Pharmacotherapy, 40, 1966-2019.
6. Liu, C. Y., Juang, Y. Y., Liang, H. Y., Lin, N. C. and Yeh, E. K. (2004). Efficacy of risperidone in treating the hyperactive symptoms of delirium. International Clinical Psychopharmacology, 19, 165-168.
7. Lonergan, E., Britton, A., Luxenberg, J. and Wyller, T. (2007). Antipsychotics for delirium. Cochrane Database Systemic Reviews, 7, CD005594.
8. Mittal, D. et al. (2004). Risperidone in the treatment of delirium: results from a prospective open-label trial. Journal of Clinical Psychiatry, 65, 662-667.
9. Miyaji, S., Yamamoto, K., Hoshino, S., Yamamoto, H., Sakai, Y. and Miyaoka, H. (2007). Comparison of the risk of adverse events between risperidone and haloperidol in delirium patients. Psychiatry and Clinical Neuroscience, 61, 275-282.
10. Onur, E. and Cimilli, C. (2005). A new approach to the treatment of delirium: atypical antipsychotics. Turk Psikiyatri Dergisi, 16, 216-224.
11. Parellada, E., Baeza, I., de Pablo, J. and Martinez, G. (2004). Risperidone in the treatment of patients with delirium. Journal of Clinical Psychiatry, 65, 348-353.
12. Rea, R. S., Battistone, S., Fong, J. J. and Devlin, J. W. (2007). Atypical antipsychotics versus haloperidol for treatment of delirium in acutely ill patients. Pharmacotherapy, 27, 588-594.
13. SAS Institute (1990). SAS/STAT Users' Guide, Version 6, 4th edn, vols. 1 and 2. Cary, NC: SAS Institute.
14. Schwartz, T. L. and Masand, P. S. (2002). The role of atypical antipsychotics in the treatment of delirium. Psychosomatics, 43, 171-174.
15. Seitz, D. P., Gill, S. S. and van Zyl, L. T. (2007). Antipsychotics in the treatment of delirium: a systematic review. Journal of Clinical Psychiatry, 68, 11-21.
16. Sipahimalani, A. and Masand, P. S. (1997). Use of risperidone in delirium: case reports. Annals of Clinical Psychiatry, 9, 105-107.